Images

1CF500038

Anti-PDX1 mouse monoclonal antibody (TA500038) immunofluorescent staining of HELA cells transiently transfected by pCMV6-ENTRY PDX1 (RC222354).

/assets/images/antibody/100/ta500038-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY PDX1 (RC222354) using anti-PDX1 antibody (TA500038/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA500038
2CF500038

Anti-PDX1 mouse monoclonal antibody (TA500038) immunofluorescent staining of HELA cells transiently transfected by pCMV6-ENTRY PDX1 (RC222354).

/assets/images/antibody/100/ta500038-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY PDX1 (RC222354) using anti-PDX1 antibody (TA500038/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA500038S
3CF500404

Flow cytometric Analysis of live Jurkat cells, using anti-CD2 antibody (TA500404 at 1:100, Red), compared to IgG1 isotype control (Black).

/assets/images/antibody/100/ta500404-1-c.jpg

Flow cytometric analysis of living 293T cells transfected with CD2 overexpression plasmid (RC206612, Red)/empty vector (PS100001, Blue) using anti-CD2 antibody (TA500404). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

TA500404
4CF500404

Flow cytometric Analysis of live Jurkat cells, using anti-CD2 antibody (TA500404 at 1:100, Red), compared to IgG1 isotype control (Black).

/assets/images/antibody/100/ta500404-1-c.jpg

Flow cytometric analysis of living 293T cells transfected with CD2 overexpression plasmid (RC206612, Red)/empty vector (PS100001, Blue) using anti-CD2 antibody (TA500404). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

TA500404S
5CF500476

Anti-IRF3 mouse monoclonal antibody (TA500476) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY IRF3 (RC209951).

/assets/images/antibody/100/ta500476-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY IRF3 (RC209951) using anti-IRF3 antibody (TA500476/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500476
6CF500476

Anti-IRF3 mouse monoclonal antibody (TA500476) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY IRF3 (RC209951).

/assets/images/antibody/100/ta500476-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY IRF3 (RC209951) using anti-IRF3 antibody (TA500476/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500476S
7CF500498

Anti-CTAG1B mouse monoclonal antibody (TA500498) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta500498-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500498/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500498
8CF500498

Anti-CTAG1B mouse monoclonal antibody (TA500498) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta500498-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500498/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500498S
9CF500528

Anti-CTAG1B mouse monoclonal antibody (TA500528) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta500528-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500528/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500528
10CF500528

Anti-CTAG1B mouse monoclonal antibody (TA500528) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta500528-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500528/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA500528S
11CF500542

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC201075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1.

/assets/images/antibody/100/ta500542-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC213858, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1 (1:2000).

TA500542
12CF500542

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC201075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1.

/assets/images/antibody/100/ta500542-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC213858, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1 (1:2000).

TA500542S
13CF500646

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500646-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500646
14CF500646

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500646-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500646S
15CF500649

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500649-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500649
16CF500649

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500649-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500649S
17CF500651

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500651-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500651
18CF500651

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500651-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500651S
19CF500652

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500652-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500652
20CF500652

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.

/assets/images/antibody/100/ta500652-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500).

TA500652S
21TA501118

Flow cytometric analysis of living 293T cells transfected with BTK overexpression plasmid (RC211582), Red)/empty vector (PS100001, Blue) using anti-BTK antibody (TA501118). Cells incubated with a non-specific antibody (Green) were used as isotype control.

/assets/images/antibody/100/ta501118-1-c.jpg

Flow cytometry analysis of monocytes from non-XLA or XLA patients using anti-BTK antibody (TA501118). Image courtesy: Dr. H. Kanaegane, University of Toyama, Japan.

CF501118
22TA501118S

Flow cytometric analysis of living 293T cells transfected with BTK overexpression plasmid (RC211582), Red)/empty vector (PS100001, Blue) using anti-BTK antibody (TA501118). Cells incubated with a non-specific antibody (Green) were used as isotype control.

/assets/images/antibody/100/ta501118-1-c.jpg

Flow cytometry analysis of monocytes from non-XLA or XLA patients using anti-BTK antibody (TA501118). Image courtesy: Dr. H. Kanaegane, University of Toyama, Japan.

CF501118
23CF501245

Anti-BIRC5 mouse monoclonal antibody (TA501245) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935).

/assets/images/antibody/100/ta501245-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA501245/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA501245
24CF501245

Anti-BIRC5 mouse monoclonal antibody (TA501245) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935).

/assets/images/antibody/100/ta501245-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA501245/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA501245S
25CF501728

Anti-SMAD2 mouse monoclonal antibody (TA501728) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604).

/assets/images/antibody/100/ta501728-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501728/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA501728
26CF501728

Anti-SMAD2 mouse monoclonal antibody (TA501728) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604).

/assets/images/antibody/100/ta501728-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501728/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA501728S
27CF501777

Anti-SMAD2 mouse monoclonal antibody (TA501777) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604).

/assets/images/antibody/100/ta501777-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501777/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA501777
28CF501777

Anti-SMAD2 mouse monoclonal antibody (TA501777) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604).

/assets/images/antibody/100/ta501777-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501777/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100).

TA501777S
29CF501778

Anti-DCX mouse monoclonal antibody (TA501778) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY DCX (RC221891).

/assets/images/antibody/100/ta501778-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY DCX (RC221891) using anti-DCX mouse monoclonal antibody (TA501778, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100).

TA501778
30CF501778

Anti-DCX mouse monoclonal antibody (TA501778) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY DCX (RC221891).

/assets/images/antibody/100/ta501778-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY DCX (RC221891) using anti-DCX mouse monoclonal antibody (TA501778, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100).

TA501778S
31CF502106

Anti-CALCOCO2 mouse monoclonal antibody (TA502106) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843).

/assets/images/antibody/100/ta502106-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502106/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502106
32CF502106

Anti-CALCOCO2 mouse monoclonal antibody (TA502106) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843).

/assets/images/antibody/100/ta502106-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502106/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502106S
33CF502153

Anti-CALCOCO2 mouse monoclonal antibody (TA502153) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843).

/assets/images/antibody/100/ta502153-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502153/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502153
34CF502153

Anti-CALCOCO2 mouse monoclonal antibody (TA502153) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843).

/assets/images/antibody/100/ta502153-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502153/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502153S
35TA502234

Flow cytometric analysis of living 293T cells transfected with BIRC5 overexpression plasmid (RC205935), Red)/empty vector (PS100001, Blue) using anti-BIRC5 antibody (TA502234). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

/assets/images/antibody/100/ta502234-1-c.jpg

HEK293T cells transfected with either RC205935 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-BIRC5 antibody (TA502234), and then analyzed by flow cytometry.

CF502234
36TA502234S

Flow cytometric analysis of living 293T cells transfected with BIRC5 overexpression plasmid (RC205935), Red)/empty vector (PS100001, Blue) using anti-BIRC5 antibody (TA502234). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

/assets/images/antibody/100/ta502234-1-c.jpg

HEK293T cells transfected with either RC205935 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-BIRC5 antibody (TA502234), and then analyzed by flow cytometry.

CF502234
37CF502236

Anti-BIRC5 mouse monoclonal antibody (TA502236) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935).

/assets/images/antibody/100/ta502236-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA502236/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502236
38CF502236

Anti-BIRC5 mouse monoclonal antibody (TA502236) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935).

/assets/images/antibody/100/ta502236-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA502236/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA502236S
39TA502832

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502832, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502832-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502832).

CF502832
40TA502832S

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502832, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502832-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502832).

CF502832
41TA502935

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502935, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502935-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502935).

CF502935
42TA502935S

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502935, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502935-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502935).

CF502935
43TA502943

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502943, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502943-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502943).

CF502943
44TA502943S

Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502943, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

/assets/images/antibody/100/ta502943-2-f.jpg

Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502943).

CF502943
45CF503933

HEK293T cells transfected with either RC207170 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CDH2 antibody (TA503933), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta503933-1-c.jpg

Living HEK293T cells transfected with either RC207170 plasmid (red) or empty vector (blue) were immunostained by anti-CDH2 antibody (TA503933) or isotype control antibody (green), and then analyzed by flow cytometry (1:50).

TA503933
46CF503933

HEK293T cells transfected with either RC207170 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CDH2 antibody (TA503933), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta503933-1-c.jpg

Living HEK293T cells transfected with either RC207170 plasmid (red) or empty vector (blue) were immunostained by anti-CDH2 antibody (TA503933) or isotype control antibody (green), and then analyzed by flow cytometry (1:50).

TA503933S
47TA504507

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME (1:500).

/assets/images/antibody/100/ta504507-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223061, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME.

CF504507
48TA504507S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME (1:500).

/assets/images/antibody/100/ta504507-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223061, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME.

CF504507
49CF504762

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504762), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504762-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504762) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504762
50CF504762

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504762), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504762-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504762) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504762S
51CF504763

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504763), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504763-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504763) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504763
52CF504763

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504763), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504763-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504763) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504763S
53CF504773

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504773), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504773-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504773) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504773
54CF504773

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504773), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504773-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504773) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504773S
55CF504773

Anti-PECAM1 mouse monoclonal antibody (TA504773) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654).

/assets/images/antibody/100/ta504773-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654) using anti-PECAM1 mouse monoclonal antibody (TA504773, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100).

TA504773
56CF504773

Anti-PECAM1 mouse monoclonal antibody (TA504773) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654).

/assets/images/antibody/100/ta504773-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654) using anti-PECAM1 mouse monoclonal antibody (TA504773, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100).

TA504773S
57CF504803

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504803), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504803-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504803) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504803
58CF504803

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504803), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504803-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504803) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504803S
59CF504804

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504804), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504804-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504804) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504804
60CF504804

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504804), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504804-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504804) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504804S
61CF504812

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504812), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504812-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504812) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504812
62CF504812

HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504812), and then analyzed by flow cytometry.

/assets/images/antibody/100/ta504812-1-c.jpg

Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504812) or isotype control antibody (green), and then analyzed by flow cytometry (1:100).

TA504812S
63TA505700

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-G (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. Positive lysates LY400968 (100ug) and LC400968 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta505700-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MAPK3 (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3.

CF505700
64TA505700S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-G (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. Positive lysates LY400968 (100ug) and LC400968 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta505700-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MAPK3 (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3.

CF505700
65CF505945

Anti-CTAG1B mouse monoclonal antibody (TA505945) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505945-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505945/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505945
66CF505945

Anti-CTAG1B mouse monoclonal antibody (TA505945) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505945-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505945/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505945S
67CF505946

Anti-CTAG1B mouse monoclonal antibody (TA505946) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505946-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505946/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505946
68CF505946

Anti-CTAG1B mouse monoclonal antibody (TA505946) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505946-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505946/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505946S
69CF505948

Anti-CTAG1B mouse monoclonal antibody (TA505948) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505948-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505948/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505948
70CF505948

Anti-CTAG1B mouse monoclonal antibody (TA505948) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505948-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505948/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505948S
71CF505951

Anti-CTAG1B mouse monoclonal antibody (TA505951) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505951-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505951/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505951
72CF505951

Anti-CTAG1B mouse monoclonal antibody (TA505951) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505951-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505951/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505951S
73CF505952

Anti-CTAG1B mouse monoclonal antibody (TA505952) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505952-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505952/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505952
74CF505952

Anti-CTAG1B mouse monoclonal antibody (TA505952) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505952-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505952/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505952S
75CF505955

Anti-CTAG1B mouse monoclonal antibody (TA505955) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505955-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505955/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505955
76CF505955

Anti-CTAG1B mouse monoclonal antibody (TA505955) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505955-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505955/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505955S
77CF505956

Anti-CTAG1B mouse monoclonal antibody (TA505956) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505956-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505956/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505956
78CF505956

Anti-CTAG1B mouse monoclonal antibody (TA505956) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505956-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505956/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505956S
79CF505959

Anti-CTAG1B mouse monoclonal antibody (TA505959) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505959-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505959/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505959
80CF505959

Anti-CTAG1B mouse monoclonal antibody (TA505959) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505959-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505959/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505959S
81CF505965

Anti-CTAG1B mouse monoclonal antibody (TA505965) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505965-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505965/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505965
82CF505965

Anti-CTAG1B mouse monoclonal antibody (TA505965) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505965-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505965/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505965S
83CF505970

Anti-CTAG1B mouse monoclonal antibody (TA505970) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505970-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505970/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505970
84CF505970

Anti-CTAG1B mouse monoclonal antibody (TA505970) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505970-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505970/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505970S
85CF505971

Anti-CTAG1B mouse monoclonal antibody (TA505971) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505971-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505971/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505971
86CF505971

Anti-CTAG1B mouse monoclonal antibody (TA505971) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505971-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505971/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505971S
87CF505972

Anti-CTAG1B mouse monoclonal antibody (TA505972) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505972-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505972/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505972
88CF505972

Anti-CTAG1B mouse monoclonal antibody (TA505972) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505972-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505972/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505972S
89CF505974

Anti-CTAG1B mouse monoclonal antibody (TA505974) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505974-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505974/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505974
90CF505974

Anti-CTAG1B mouse monoclonal antibody (TA505974) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318).

/assets/images/antibody/100/ta505974-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505974/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA505974S
91CF506331

Anti-FCGR1A mouse monoclonal antibody (TA506331) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FCGR1A (RC207487).

/assets/images/antibody/100/ta506331-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY FCGR1A (RC207487) using anti-FCGR1A antibody (TA506331/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA506331
92CF506331

Anti-FCGR1A mouse monoclonal antibody (TA506331) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FCGR1A (RC207487).

/assets/images/antibody/100/ta506331-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY FCGR1A (RC207487) using anti-FCGR1A antibody (TA506331/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA506331S
93CF506350

Anti-CD33 mouse monoclonal antibody (TA506350) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD33 (RC207023).

/assets/images/antibody/100/ta506350-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CD33 (RC207023) using anti-CD33 antibody (TA506350/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA506350
94CF506350

Anti-CD33 mouse monoclonal antibody (TA506350) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD33 (RC207023).

/assets/images/antibody/100/ta506350-1-f.jpg

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CD33 (RC207023) using anti-CD33 antibody (TA506350/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

TA506350S
95CF506392

Anti-CD163 mouse monoclonal antibody (TA506392) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD163 (RC208557).

/assets/images/antibody/100/ta506392-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY CD163 (RC208557}) using anti-CD163 mouse monoclonal antibody (TA506392, green, upper left; merged, upper right) or empty vector control plasmid ( merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

TA506392
96CF506392

Anti-CD163 mouse monoclonal antibody (TA506392) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD163 (RC208557).

/assets/images/antibody/100/ta506392-1-f.jpg

Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY CD163 (RC208557}) using anti-CD163 mouse monoclonal antibody (TA506392, green, upper left; merged, upper right) or empty vector control plasmid ( merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100).

TA506392S
97CF507240

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507240-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507240
98CF507240

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507240-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507240S
99CF507243

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507243-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507243
100CF507243

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507243-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507243S
101CF507244

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507244-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507244
102CF507244

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507244-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507244S
103CF507245

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507245-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507245
104CF507245

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1.

/assets/images/antibody/100/ta507245-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500).

TA507245S
105TA801872

E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000).

/assets/images/antibody/100/ta801872-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16.

CF801872
106TA801872S

E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000).

/assets/images/antibody/100/ta801872-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16.

CF801872
107TA801881

E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000).

/assets/images/antibody/100/ta801881-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16.

CF801881
108TA801881S

E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000).

/assets/images/antibody/100/ta801881-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16.

CF801881
109TA801940

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801940), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801940-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801940), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801940
110TA801940S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801940), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801940-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801940), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801940
111CF801941

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta801941-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then analyzed by flow cytometry (1:100).

TA801941
112CF801941

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta801941-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then analyzed by flow cytometry (1:100).

TA801941S
113TA801941

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801941), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801941-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801941), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801941
114TA801941S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801941), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801941-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801941), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801941
115TA801972

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801972), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801972-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801972), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801972
116TA801972S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801972), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta801972-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801972), (Red), compared to a nonspecific negative control antibody, (Blue).

CF801972
117TA802083

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802083), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802083-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802083), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802083
118TA802083S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802083), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802083-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802083), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802083
119CF802218

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC201301, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3.

/assets/images/antibody/100/ta802218-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC231040, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3 (1:500).

TA802218
120CF802218

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC201301, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3.

/assets/images/antibody/100/ta802218-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC231040, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3 (1:500).

TA802218S
121CF802402

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802402-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then analyzed by flow cytometry (1:100).

TA802402
122CF802402

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802402-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then analyzed by flow cytometry (1:100).

TA802402S
123TA802402

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802402), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802402-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802402), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802402
124TA802402S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802402), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802402-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802402), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802402
125TA802403

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802403), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802403-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802403), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802403
126TA802403S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802403), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802403-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802403), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802403
127CF802404

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802404-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then analyzed by flow cytometry (1:100).

TA802404
128CF802404

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802404-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then analyzed by flow cytometry (1:100).

TA802404S
129TA802404

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802404), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802404-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802404), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802404
130TA802404S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802404), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802404-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802404), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802404
131CF802406

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802406-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then analyzed by flow cytometry (1:100).

TA802406
132CF802406

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802406-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then analyzed by flow cytometry (1:100).

TA802406S
133TA802406

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802406), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802406-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802406), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802406
134TA802406S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802406), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802406-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802406), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802406
135TA802408

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802408), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802408-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802408), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802408
136TA802408S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802408), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802408-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802408), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802408
137CF802409

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802409-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then analyzed by flow cytometry (1:100).

TA802409
138CF802409

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802409-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then analyzed by flow cytometry (1:100).

TA802409S
139TA802409

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802409), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802409-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802409), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802409
140TA802409S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802409), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802409-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802409), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802409
141CF802410

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802410-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then analyzed by flow cytometry (1:100).

TA802410
142CF802410

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802410-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then analyzed by flow cytometry (1:100).

TA802410S
143TA802410

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802410), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802410-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802410), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802410
144TA802410S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802410), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802410-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802410), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802410
145TA802411

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802411), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802411-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802411), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802411
146TA802411S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802411), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802411-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802411), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802411
147CF802415

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802415-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then analyzed by flow cytometry (1:100).

TA802415
148CF802415

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802415-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then analyzed by flow cytometry (1:100).

TA802415S
149TA802415

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802415), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802415-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802415), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802415
150TA802415S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802415), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802415-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802415), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802415
151CF802417

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802417-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then analyzed by flow cytometry (1:100).

TA802417
152CF802417

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802417-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then analyzed by flow cytometry (1:100).

TA802417S
153TA802417

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802417), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802417-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802417), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802417
154TA802417S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802417), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802417-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802417), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802417
155TA802418

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802418), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802418-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802418), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802418
156TA802418S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802418), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802418-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802418), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802418
157CF802422

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802422-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then analyzed by flow cytometry (1:100).

TA802422
158CF802422

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802422-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then analyzed by flow cytometry (1:100).

TA802422S
159TA802423

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802423), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802423-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802423), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802423
160TA802423S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802423), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802423-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802423), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802423
161CF802424

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802424-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then analyzed by flow cytometry (1:100).

TA802424
162CF802424

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802424-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then analyzed by flow cytometry (1:100).

TA802424S
163TA802424

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802424), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802424-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802424), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802424
164TA802424S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802424), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802424-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802424), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802424
165TA802425

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802425), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802425-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802425), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802425
166TA802425S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802425), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802425-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802425), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802425
167CF802427

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802427-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then analyzed by flow cytometry (1:100).

TA802427
168CF802427

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802427-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then analyzed by flow cytometry (1:100).

TA802427S
169TA802427

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802427), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802427-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802427), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802427
170TA802427S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802427), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802427-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802427), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802427
171CF802428

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802428-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then analyzed by flow cytometry (1:100).

TA802428
172CF802428

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802428-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then analyzed by flow cytometry (1:100).

TA802428S
173TA802428

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802428), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802428-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802428), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802428
174TA802428S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802428), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802428-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802428), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802428
175CF802439

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802439-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then analyzed by flow cytometry (1:100).

TA802439
176CF802439

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802439-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then analyzed by flow cytometry (1:100).

TA802439S
177TA802439

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802439), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802439-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802439), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802439
178TA802439S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802439), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802439-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802439), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802439
179CF802440

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802440-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then analyzed by flow cytometry (1:100).

TA802440
180CF802440

HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then living cells were analyzed by flow cytometry.

/assets/images/antibody/100/ta802440-1-c.jpg

Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then analyzed by flow cytometry (1:100).

TA802440S
181TA802440

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802440), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802440-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802440), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802440
182TA802440S

Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802440), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100).

/assets/images/antibody/100/ta802440-9-c.jpg

Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802440), (Red), compared to a nonspecific negative control antibody, (Blue).

CF802440
183TA802443

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802443-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802443
184TA802443S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802443-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802443
185TA802572

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802572-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802572
186TA802572S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802572-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802572
187TA802588

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802588-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802588
188TA802588S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene.

/assets/images/antibody/100/ta802588-1-w.jpg

HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244).

CF802588
189TA803259

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803259-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803259
190TA803259S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803259-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803259
191TA803275

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803275-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803275
192TA803275S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803275-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803275
193TA803310

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803310-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803310
194TA803310S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500).

/assets/images/antibody/100/ta803310-1-w.jpg

SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF

CF803310
195TA804902

Western blot analysis of extracts (35ug) from different cell line by using anti-CTNND1 monoclonal antibody (1:500).

/assets/images/antibody/100/ta804902-8-w.jpg

Western blot analysis of extracts (35ug) from HepG2 cell line by using anti-ASL monoclonal antibody (1:500).

CF804902
196TA804902S

Western blot analysis of extracts (35ug) from different cell line by using anti-CTNND1 monoclonal antibody (1:500).

/assets/images/antibody/100/ta804902-8-w.jpg

Western blot analysis of extracts (35ug) from HepG2 cell line by using anti-ASL monoclonal antibody (1:500).

CF804902
197TA804937

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220449, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4 (1:500).

/assets/images/antibody/100/ta804937-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220500, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4.

CF804937
198TA804937S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220449, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4 (1:500).

/assets/images/antibody/100/ta804937-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220500, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4.

CF804937
199CF805640

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 (1:2000).

/assets/images/antibody/100/ta805640-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

TA805640
200CF805640

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 (1:2000).

/assets/images/antibody/100/ta805640-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

TA805640S
201TA805648

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805648-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805648
202TA805648S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805648-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805648
203TA805653

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805653-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805653
204TA805653S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805653-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805653
205TA805656

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805656-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805656
206TA805656S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805656-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805656
207TA805657

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805657-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805657
208TA805657S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805657-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805657
209TA805671

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805671-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805671
210TA805671S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500`

/assets/images/antibody/100/ta805671-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli.

CF805671
211TA806188

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500).

/assets/images/antibody/100/ta806188-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli.

CF806188
212TA806188S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500).

/assets/images/antibody/100/ta806188-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli.

CF806188
213TA806197

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500).

/assets/images/antibody/100/ta806197-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli.

CF806197
214TA806197S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500).

/assets/images/antibody/100/ta806197-1-w.jpg

Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli.

CF806197
215CF806586

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDCD1LG2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDCD1LG2.

/assets/images/antibody/100/ta806586-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDL2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDL2 (1:1k)

TA806586
216CF806586

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDCD1LG2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDCD1LG2.

/assets/images/antibody/100/ta806586-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDL2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDL2 (1:1k)

TA806586S
217CF806803

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:2000).

/assets/images/antibody/100/ta806803-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:500).

TA806803
218CF806803

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:2000).

/assets/images/antibody/100/ta806803-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:500).

TA806803S
219CF806846

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000).

/assets/images/antibody/100/ta806846-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500).

TA806846
220CF806846

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000).

/assets/images/antibody/100/ta806846-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500).

TA806846S
221CF806847

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000).

/assets/images/antibody/100/ta806847-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500).

TA806847
222CF806847

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000).

/assets/images/antibody/100/ta806847-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500).

TA806847S
223TA807180

Flow cytometric analysis of living 293T cells transfected with LAG3 overexpression plasmid (RC220269), Red)/empty vector (PS100001, Blue) using anti-LAG3 antibody (TA807180). Cells incubated with a non-specific antibody (Green) were used as isotype control. (1;100)

/assets/images/antibody/100/ta807180-1-c.jpg

HEK293T cells transfected with either empty vector control plasmid (A), RC220269 overexpress plasmid (B) were immunostained by anti-LAG3 antibody (Origene, TA807180, Red), compared to an IgG isotype control (Origene, TA180144, blue) or PBS (black)then analyzed by flow cytometry. (1:100).

CF807180
224TA807180S

Flow cytometric analysis of living 293T cells transfected with LAG3 overexpression plasmid (RC220269), Red)/empty vector (PS100001, Blue) using anti-LAG3 antibody (TA807180). Cells incubated with a non-specific antibody (Green) were used as isotype control. (1;100)

/assets/images/antibody/100/ta807180-1-c.jpg

HEK293T cells transfected with either empty vector control plasmid (A), RC220269 overexpress plasmid (B) were immunostained by anti-LAG3 antibody (Origene, TA807180, Red), compared to an IgG isotype control (Origene, TA180144, blue) or PBS (black)then analyzed by flow cytometry. (1:100).

CF807180
225CF807239

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:2000).

/assets/images/antibody/100/ta807239-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:500).

TA807239
226CF807239

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:2000).

/assets/images/antibody/100/ta807239-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:500).

TA807239S
227CF807341

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000).

/assets/images/antibody/100/ta807341-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500).

TA807341
228CF807341

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000).

/assets/images/antibody/100/ta807341-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500).

TA807341S
229CF807531

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000).

/assets/images/antibody/100/ta807531-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500).

TA807531
230CF807531

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000).

/assets/images/antibody/100/ta807531-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500).

TA807531S
231CF808748

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808748) (1:50)

/assets/images/antibody/100/ta808748-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808748) (1:50)

TA808748
232CF808748

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808748) (1:50)

/assets/images/antibody/100/ta808748-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808748) (1:50)

TA808748S
233CF808749

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808749) (1:50)

/assets/images/antibody/100/ta808749-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808749) (1:50)

TA808749
234CF808749

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808749) (1:50)

/assets/images/antibody/100/ta808749-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808749) (1:50)

TA808749S
235CF808752

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808752) (1:50)

/assets/images/antibody/100/ta808752-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808752) (SUPERTN) (1:50)

TA808752
236CF808752

Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808752) (1:50)

/assets/images/antibody/100/ta808752-24-c.jpg

Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808752) (SUPERTN) (1:50)

TA808752S
237TA809097

Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809097-8-w.jpg

Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200).

CF809097
238TA809097S

Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809097-8-w.jpg

Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200).

CF809097
239TA809143

Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809143-8-w.jpg

Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200).

CF809143
240TA809143S

Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809143-8-w.jpg

Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200).

CF809143
241TA809316

Western blot analysis of extracts (35ug) from 5 different cell lines and human plasma by using anti-IRF3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809316-8-w.jpg

Western blot analysis of extracts (35ug) from 6 different cell lines by using anti-IRF3 monoclonal antibody (1:500).

CF809316
242TA809316S

Western blot analysis of extracts (35ug) from 5 different cell lines and human plasma by using anti-IRF3 monoclonal antibody (1:500).

/assets/images/antibody/100/ta809316-8-w.jpg

Western blot analysis of extracts (35ug) from 6 different cell lines by using anti-IRF3 monoclonal antibody (1:500).

CF809316
243TA809425

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC209951, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:500).

/assets/images/antibody/100/ta809425-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC231144, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:2000).

CF809425
244TA809425S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC209951, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:500).

/assets/images/antibody/100/ta809425-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC231144, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:2000).

CF809425
245TA809449

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809449-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809449
246TA809449S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809449-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809449
247TA809456

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809456-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809456
248TA809456S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809456-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809456
249TA809457

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809457-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809457
250TA809457S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500).

/assets/images/antibody/100/ta809457-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000).

CF809457
251CF809460

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:2000).

/assets/images/antibody/100/ta809460-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:500).

TA809460
252CF809460

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:2000).

/assets/images/antibody/100/ta809460-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:500).

TA809460S
253TA809831

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000).

/assets/images/antibody/100/ta809831-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000).

CF809831
254TA809831S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000).

/assets/images/antibody/100/ta809831-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000).

CF809831
255TA809834

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000).

/assets/images/antibody/100/ta809834-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000).

CF809834
256TA809834S

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000).

/assets/images/antibody/100/ta809834-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000).

CF809834
257TA810027

Western blot analysis of extracts (35ug) from 17 different cell lines by using anti-POLR2A monoclonal antibody. 1:500`

/assets/images/antibody/100/ta810027-8-w.jpg

Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500).

CF810027
258TA810027S

Western blot analysis of extracts (35ug) from 17 different cell lines by using anti-POLR2A monoclonal antibody. 1:500`

/assets/images/antibody/100/ta810027-8-w.jpg

Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500).

CF810027
259TA810050

Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-POLR2A monoclonal antibody. 1:500`

/assets/images/antibody/100/ta810050-8-w.jpg

Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500).

CF810050
260TA810050S

Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-POLR2A monoclonal antibody. 1:500`

/assets/images/antibody/100/ta810050-8-w.jpg

Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500).

CF810050
261TA810605

Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500).

/assets/images/antibody/100/ta810605-8-w.jpg

Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500).

CF810605
262TA810605S

Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500).

/assets/images/antibody/100/ta810605-8-w.jpg

Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500).

CF810605
263TA810614

Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500).

/assets/images/antibody/100/ta810614-8-w.jpg

Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500).

CF810614
264TA810614S

Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500).

/assets/images/antibody/100/ta810614-8-w.jpg

Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500).

CF810614
265CF810942

Western blot analysis of extracts (35ug) from 2 different cell lines by using anti-HOXD8 monoclonal antibody (1:500).

/assets/images/antibody/100/ta810942-8-w.jpg

Western blot analysis of extracts (35ug) from A375 cell by using anti-HOXD8 monoclonal antibody (1:500).

TA810942
266CF810942

Western blot analysis of extracts (35ug) from 2 different cell lines by using anti-HOXD8 monoclonal antibody (1:500).

/assets/images/antibody/100/ta810942-8-w.jpg

Western blot analysis of extracts (35ug) from A375 cell by using anti-HOXD8 monoclonal antibody (1:500).

TA810942S
267TA810988

Western blot analysis of extracts (35ug) from 5 cell lines lysates by using anti-ASH2L monoclonal antibody (1:500).

/assets/images/antibody/100/ta810988-8-w.jpg

Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-ASH2L monoclonal antibody (1:500).

CF810988
268TA810988S

Western blot analysis of extracts (35ug) from 5 cell lines lysates by using anti-ASH2L monoclonal antibody (1:500).

/assets/images/antibody/100/ta810988-8-w.jpg

Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-ASH2L monoclonal antibody (1:500).

CF810988
269CF811879

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:2000).

/assets/images/antibody/100/ta811879-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:500).

TA811879
270CF811879

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:2000).

/assets/images/antibody/100/ta811879-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:500).

TA811879S
271CF813014

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, red), compared to an IgG isotype control (blue) (1:100).

/assets/images/antibody/100/ta813014-16-c.jpg

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, Tecentriq, red), compared to an IgG isotype control (blue) (1:100).

TA813014S
272TA813014

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, red), compared to an IgG isotype control (blue) (1:100).

/assets/images/antibody/100/ta813014-16-c.jpg

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, Tecentriq, red), compared to an IgG isotype control (blue) (1:100).

TA813014S
273CF813014

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Red) compared to an IgG isotype control antibody (Blue) (1:100).

/assets/images/antibody/100/ta813014-20-c.jpg

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Tecentriq) (Red) compared to an IgG isotype control antibody (Blue) (1:100).

TA813014S
274TA813014

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Red) compared to an IgG isotype control antibody (Blue) (1:100).

/assets/images/antibody/100/ta813014-20-c.jpg

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Tecentriq) (Red) compared to an IgG isotype control antibody (Blue) (1:100).

TA813014S
275TA813015S

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, Avelumab, red), compared to an IgG isotype control (blue) (1:100).

/assets/images/antibody/100/ta813015-16-c.jpg

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, red), compared to an IgG isotype control (blue) (1:100).

CF813015
276TA813015S

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, Avelumab, red), compared to an IgG isotype control (blue) (1:100).

/assets/images/antibody/100/ta813015-16-c.jpg

Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, red), compared to an IgG isotype control (blue) (1:100).

TA813015
277TA813015S

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Avelumab) (Red) compared to an IgG isotype control antibody (Blue) (1:100).

/assets/images/antibody/100/ta813015-20-c.jpg

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Red) compared to an IgG isotype control antibody (Blue) (1:100).

CF813015
278TA813015S

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Avelumab) (Red) compared to an IgG isotype control antibody (Blue) (1:100).

/assets/images/antibody/100/ta813015-20-c.jpg

Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Red) compared to an IgG isotype control antibody (Blue) (1:100).

TA813015
279TA324829

Fluorescent confocal image of Hela cell stained with MEF2C Antibody (S387).Hela cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.1%, 10 min), then incubated with MEF2C primary antibody (1:25, 1 h at 37°C). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400, 50 min at 37°C).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7units/ml, 1 h at 37°C). Nuclei were counterstained with DAPI (blue) (10 ug/ml, 10 min).MEF2C immunoreactivity is localized to vesicles and Nucleus significantly.

/assets/images/antibody/101/ap6285a-1-f.jpg

IF image of Hela cell stained with MEF2C Antibody (S387) (Cat#TA302220).Hela cells were incubated with MEF2C primary antibody (1:25, 1 h at 37°C). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7 units/ml). Nuclei were counterstained with DAPI (blue).MEF2C immunoreactivity is localized to vesicles and Nucleus significantly.

TA302220
280TA302220

Formalin-fixed and paraffin-embedded human brain tissue reacted with MEF2C Antibody (S387) (Cat.#TA302220), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

/assets/images/antibody/101/ap6285a-1-h.jpg

Formalin-fixed and paraffin-embedded human brain tissue reacted with MEF2C Antibody (S387), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

TA324829
281TA302220

MEF2C Antibody (pS387) (Cat. #TA302220) western blot analysis in HL-60, K562 cell line lysates (35ug/lane).This demonstrates the MEF2C antibody detected the MEF2C protein (arrow).

/assets/images/antibody/101/ap6285a-1-w.jpg

MEF2C Antibody (pS387) western blot analysis in HL-60, K562 cell line lysates (35ug/lane).This demonstrates the MEF2C antibody detected the MEF2C protein (arrow).

TA324829
282TA354995

Immunofluorescence of NALP3 in K562 cells with NALP3 antibody at 20ug/ml.

/assets/images/antibody/110/5447-1-f.jpg

Immunofluorescence of NALP3 in K562 cells with NALP3 antibody at 5ug/ml.

TA306860
283TA160032

Hemagglutinin antibody at 2 ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein.

/assets/images/antibody/110/pm-4005-1-e.jpg

Hemagglutinin antibody at 2ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein.

TA160209
284TA160033

Hemagglutinin antibody at 2 ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein.

/assets/images/antibody/110/pm-4006-1-e.jpg

Hemagglutinin antibody at 2ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein.

TA160210
285TA160034

Western blot analysis of (A) 5 ng and (B) 25 ng of recombinant HA1 with Hemagglutinin antibody at 1 ug/mL.

/assets/images/antibody/110/pm-4007-1-w.jpg

Western blot analysis of (A) 5 ng and (B) 25 ng of recombinant HA1 with Hemagglutinin antibody at 1ug/mL.

TA160211
286TA160216

Seasonal Influenza A Hemagglutinin antibody (2ug/mL) recognizes seasonal influenza A (H1N1), but not swine-origin influenza A (S-OIV, H1N1), Hemagglutinin protein in ELISA.

/assets/images/antibody/110/pm-5533-1-e.jpg

Seasonal Influenza A Hemagglutinin antibody recognizes seasonal influenza A (H1N1), but not swine-origin influenza A (S-OIV, H1N1), Hemagglutinin protein in ELISA.

TA160039
287TA160044

Western blot analysis of 20 ng of (A) viral p24 and (B) recombinant p24 with anti-HIV-1 p24 antibody at (A) 0.5 ug/mL and (B) 0.2 ug/mL, respectively.

/assets/images/antibody/110/pm-6335-1-w.jpg

Western blot analysis of 20 ng of (A) viral p24 and (B) recombinant p24 with anti-HIV-1 p24 antibody PM-6335 at (A) 0.5 ug/mL and (B) 0.2 ug/mL, respectively.

TA160221
288TA160126

Adenosine-3', 5'-cyclic AMP immorbolized onto plates, followed by addition of stand cyclic AMP. The mouse anti c-AMP was added subsequentially, and visiualized by chromatogenic substrate. Each sample was triplicate. IC50 was then calculated.

/assets/images/antibody/138/500-9534-1-e.jpg

ELISA: Adenosine-3', 5'-cyclic AMP immorbolized onto plates, followed by addition of stand cyclic AMP. The mouse anti-c-AMP antibody was added subsequentially, and visiualized by chromatogenic substrate. Each sample was triplicate. IC50 was then calculated.

TA354437
289TA100033

HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution.

TA100032
290TA100033

HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000).

TA180011
291TA100032

HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000).

TA180011
292TA100034

HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution.

TA100033
293TA100034

HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution.

TA100032
294TA100034

HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution.

/assets/images/antibody/antitag/ta180011-1-w.jpg

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000).

TA180011
295UM500012

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500012/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

/assets/images/ultramab/um500012-1-f.jpg

Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500012, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner.

UM500012CF
296UM500012

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500012/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

/assets/images/ultramab/um500012-1-f.jpg

Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500012, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner.

UM570012
297UM500013

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500013/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

/assets/images/ultramab/um500013-1-f.jpg

Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500013, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner.

UM500013CF
298UM500013

Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500013/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100).

/assets/images/ultramab/um500013-1-f.jpg

Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500013, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner.

UM570013
299UM500023

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDH2 (RC207170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDH2 mouse monoclonal antibody (1:1000).

/assets/images/ultramab/um500023-1-w.jpg

Western Blot analysis of extracts (35ug) from 11 different cell lines by using anti-CDH2 monoclonal antibody (Clone UMAB23)

UM570023
300UM500023

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDH2 (RC207170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDH2 mouse monoclonal antibody (1:1000).

/assets/images/ultramab/um500023-1-w.jpg

Western Blot analysis of extracts (35ug) from 11 different cell lines by using anti-CDH2 monoclonal antibody (Clone UMAB23)

UM500023CF
301UM500031

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PECAM1 (RC208654, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PECAM1 mouse monoclonal antibody.1:500`

/assets/images/ultramab/um500031-1-w.jpg

Western Blot analysis of MOLT-4 cell lysate (35ug) by using anti-PECAM1 monoclonal antibody (Clone UMAB31)

UM500031CF
302UM500031

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PECAM1 (RC208654, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PECAM1 mouse monoclonal antibody.1:500`

/assets/images/ultramab/um500031-1-w.jpg

Western Blot analysis of MOLT-4 cell lysate (35ug) by using anti-PECAM1 monoclonal antibody (Clone UMAB31)

UM570031
303UM500098

Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-18-w.jpg

Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM570098
304UM500098

Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-18-w.jpg

Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM500098CF
305UM500098

Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-24-w.jpg

Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM500098CF
306UM500098

Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-24-w.jpg

Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM570098
307UM500098

Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-27-w.jpg

Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM570098
308UM500098

Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000).

/assets/images/ultramab/um500098-27-w.jpg

Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody.

UM500098CF
309UM500099

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD44 (RC221771, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates were separated by SDS-PAGE and immunoblotted with anti-CD44 (1:500).

/assets/images/ultramab/um500099-1-w.jpg

Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD44 monoclonal antibody (Clone UMAB134)

UM570099
310UM500099

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD44 (RC221771, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates were separated by SDS-PAGE and immunoblotted with anti-CD44 (1:500).

/assets/images/ultramab/um500099-1-w.jpg

Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD44 monoclonal antibody (Clone UMAB134)

UM500099CF
311UM800008

OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57 ) very specifically recognizes MUC1 antigen on OriGene protein microarray chip (1:100).

/assets/images/ultramab/um800008-1-k.jpg

OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57) very specifically recognizes MUC1 antigen on OriGene protein microarray chip.

UM870008
312UM800008

OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57 ) very specifically recognizes MUC1 antigen on OriGene protein microarray chip (1:100).

/assets/images/ultramab/um800008-1-k.jpg

OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57) very specifically recognizes MUC1 antigen on OriGene protein microarray chip.

UM800008CF
313UM800017

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD2 (RC206612, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD2 (1:500).

/assets/images/ultramab/um800017-1-w.jpg

Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD2 monoclonal antibody (Clone UMAB86)

UM800017CF
314UM800017

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD2 (RC206612, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD2 (1:500).

/assets/images/ultramab/um800017-1-w.jpg

Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD2 monoclonal antibody (Clone UMAB86)

UM870017
315UM800115

Flow cytometric analysis of living 293T cells transfected with PDL2 overexpression plasmid (RC224141, Red)/empty vector (PS100001, Blue) using anti-PDL2 antibody (UM800115). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

/assets/images/ultramab/um800115-1-c.jpg

HEK293T cells transfected with either RC224141 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PDCD1LG2 antibody (UM800115), and then analyzed by flow cytometry (1:100).

UM870115
316UM800115

Flow cytometric analysis of living 293T cells transfected with PDL2 overexpression plasmid (RC224141, Red)/empty vector (PS100001, Blue) using anti-PDL2 antibody (UM800115). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

/assets/images/ultramab/um800115-1-c.jpg

HEK293T cells transfected with either RC224141 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PDCD1LG2 antibody (UM800115), and then analyzed by flow cytometry (1:100).

UM800115CF